Putative role of an ABC transporter in Fonsecaea pedrosoi multidrug resistance

Luciana P Rangel1, Otacílio C Moreira, Gustavo N Livramento

  • 1Departamento de Microbiologia Geral, Laboratório de Bioquímica Microbiana/IMPPG, CCS, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Cidade Universitária, CEP 21941902, Rio de Janeiro, Brazil.

Insights

This study characterizes an ATP-binding cassette (ABC) transporter in Fonsecaea pedrosoi, linking its expression to drug resistance in chromoblastomycosis treatment. Understanding this transporter is crucial for developing new antifungal therapies.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Biochemistry

Background:

  • Chromoblastomycosis, caused by Fonsecaea pedrosoi, is a chronic fungal infection characterized by skin and subcutaneous lesions.
  • Treatment is challenging due to antifungal drug toxicity and emerging resistance.
  • ATP-binding cassette (ABC) transporters are implicated in multidrug resistance across various organisms.

Purpose of the Study:

  • To characterize an ATP-binding cassette (ABC) transporter in Fonsecaea pedrosoi.
  • To investigate the relationship between ABC transporter expression and drug resistance in F. pedrosoi.
  • To explore the potential of this transporter as a target for novel antifungal strategies.

Main Methods:

  • Western blotting to detect a 150 kDa protein.
  • ATPase activity assays on membrane preparations.
  • Reverse transcription polymerase chain reaction (RT-PCR) to detect the ATP-binding domain.

Main Results:

  • A 150 kDa protein, likely an ABC transporter, was detected.
  • The transporter exhibited ATPase activity and responded to classical inhibitors, similar to Saccharomyces cerevisiae Pdr5p.
  • RT-PCR confirmed the presence of a conserved ATP-binding domain (400 bp product).
  • Higher expression of the ABC transporter correlated with increased drug resistance in F. pedrosoi strains.

Conclusions:

  • An ABC transporter is involved in Fonsecaea pedrosoi multidrug resistance.
  • Characterization of this ABC transporter provides insights into fungal drug resistance mechanisms.
  • Further understanding of this protein could significantly contribute to improving antifungal treatments for chromoblastomycosis.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...